A nationwide survey of hepatic angiosarcoma (HAS) in the United States during the years 1964 through 1974 identified 168 cases. Of these, 42 cases (25%) were associated with known etiologic factors, such as vinyl chloride monomer exposure during preparation of poly(vinyl chloride), use of Thorotrast in angiography, exposure to inorganic arsenic, and treatment with androgenicanabolic steroids; 126 cases (75%) are of uncertain etiology. HAS most often affects males (ratio of approximately 3:1), peaks in the sixth and seventh decades of life (somewhat earlier than other sarcomas of the liver) and appears to occur more often in the industrialized Northeast and Midwest (although reporting artifact may be a factor). There is an extraordinary relative risk for poly(vinyl chloride) polymerization workers; there may also be other chemical-industrial associations that require further investigation. Prospective epidemiologic studies of HAS should be considered as a means of identifying other causative factors (e.g., chemicals or drugs) related to HAS.
Introduction
This report is an overview of the nationwide hepatic angiosarcoma (HAS) case-finding study for the years [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] conducted by the Centers for Disease Control (CDC).
At the start of this study, three causative factors had been identified for HAS: vinyl chloride monomer (VCM) (1, 2) , Thorotrast (3) , and inorganic arsenic (4) . The recently discovered association between VCM and HAS has served as a stimulus for this investigation, and multiple epidemiologic studies of polyvinyl chloride (PVC) polymerization workers exposed to VCM have since demonstrated very high relative risks for the development of HAS (5, 6) . Thorotrast is a colloidal suspension of thorium dioxide, a radioactive alpha-emitter with markedly prolonged radiologic and biologic halflives, which was used for carotid angiography and liver-spleen scans in the period . The thorium dioxide is sequestered by the reticuloendothelial system, primarily in the Kupffer cells of the liver; radiation injury to adjacent cells is the presumed carcinogenic mechanism. Epidemiologic studies of Thorotrast recipients have shown very high relative risks for the development of HAS as well as hepatocellular tumors (7, 8) . The association between arsenic and HAS is based on data from several small autopsy series in German vintners in the 1940s and 1950s (4, 9) , which demonstrated an increased incidence of liver disease, including HAS. These workers were exposed to inorganic arsenical pesticides during application of the pesticide and also by drinking beverages prepared from the skins of the sprayed grapes. Subsequently, HAS cases were reported following long-term ingestion of Fowler's solution (potassium arsenite) (10, 11) and October 1981 arsenic-contaminated well water (12) . Individual cases suggesting associations between HAS and hemochromatosis (13) and copper exposure (14) have also been reported.
Earlier reports from this study reviewed cases associated with single causative factors (15) (16) (17) (18) , including androgenic-anabolic steroids which we feel are implicated as a fourth cause of HAS (19) in the review; (6) a number of cases were identified from industrial surveys of PVC polymerization workers and others potentially exposed to VCM; and (7) permission was requested to include the previously published cases of HAS occurring in [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] .
The evaluation procedure for each identified case was as follows: Initially, permission was requested to review the appropriate pathologic specimens (all submitted non-AFIP case material was reviewed at the National Cancer Institute's Laboratory of Pathology by H. P. and L. B. T.). Following confirnation of the diagnosis, the local physician was notified, and, with his permission, the nearest of kin was identified and contacted. Consent was obtained to review medical records, and a questionnaire was administered by telephone to obtain detailed occupational, residential, and chemical exposure histories. In selected instances, friends, employers, previous physicians or others were Up to four controls (as many as were available) were matched to each case , 30 years of age on the basis of the following criteria: age (+6 years), sex, race, county of residence, and year of death (+3 years). One hundred thirty-five cases were successfully matched (79 of these had 4 matched controls; the overall ratio of controls to cases was approximately 3:1). Individuals who could not be matched were primarily young females and residents of sparsely populated counties.
A combined occupation and industry coding scheme was developed to accommodate all listings recorded on the certificates and to group listings on the basis of potential hazardous exposures. The data were analyzed by Rothman's method for matched groups with multiple controls per case (20) .
Results
Our study identified 168 deaths from confirmed HAS during the years 1964 through 1974. For this rare tumor, the best sources of case identification were the pathologists, with the largest number of cases identified through the single mailing to all pathologists and the second largest number of cases Environmental Health Perspectives identified through pathology referral centers (particularly the AFIP). (Fig. 2) and is associated with a younger peak age for males than females, although the mean age for female HAS cases (50.1 years) is lower than that for males (57.9 years). These findings are not solely related to the VCM-induced cases among polymerization workers. The male preponderance is also present in the Thorotrast, arsenic, and androgenicanabolic steroid associated cases, as well as in the idiopathic cases (Table 2) . Cases with known etiology, however, have a younger age distribution than idiopathic cases (Table 3) , with a mean age of 51.0 years compared to 57.6 years for the idiopathic cases. (Table 5 ), suggest a somewhat higher incidence in the Northeast and in the industrial portions of the Midwest. There was also an increase in the mountain region, although this is based on a very small number of cases. The rates were low in farming states and in the South; however, since Environmental Health Perspectives many cases are diagnosed only after referral to major hospital and tumor centers, it is possible that low rural rates could be artifactual.
To summarize this portion of the study, it is apparent that HAS has a strong male preponderance, that it appears to occur more often in younger age groups than other sarcomas of the liver, and that there may be geographic differences which are unrelated simply to the distribution of VCM associated cases (the largest number of which were in Kentucky and West Virginia). As part of the follow-up effort we looked at occupation in the death certificate case-control study. Table 6 shows that the case-control ratios were elevated only for the last two occupational categories. The first of these (#7) shows a highly significant difference for chemical workers that is entirely related to exposure to VCM; all 10 cases were PVC polymerization workers. The last category (#8) combined a large number of laboring groups with potential exposure to a variety of chemicals; included are laborers, machinists, maintenance workers and others. The association of this heterogeneous grouping of occupations with HAS is not statistically significant, nor in reviewing the individual occupational data from the interviews with family members were we able to identify a specific chemical, plant, or process as a causative factor. Nevertheless, taken together with the earlier findings, this association suggests that some chemical exposure or industrial factors may be related to a portion of the idiopathic cases. Such an association would not be unreasonable; machinists, e.g., are potentially exposed to trichloroethylene (an experimental hepatocarcinogen that is structurally related to vinyl chloride), inorganic arsenic and nitrosamines (which have been identified in cutting fluids and are a known cause of HAS in animals) (22, 23) .
Discussion
A particularly intriguing feature of HAS is that there are now four probable causes of this tumor, and yet about 75% of the cases are of uncertain etiology. Given that the HAS cases associated with the four quite distinct etiologic factors (VCM, Thorotrast, arsenic, and androgenic-anabolic steroids) share a common morphologic progression to HAS which is indistinguishable from that of idiopathic cases (24) , it is likely that additional causal factors are (or will be) associated with HAS. In this study, the male preponderance, the younger age distribution, the possible geographic relationship with industrial portions of the country, and the suggestion from the death certificate case-control October 1981 study that groups with chemical exposure may be at higher risk, raise the possibility that some of the idiopathic cases may be related to presently unidentified environmental or occupational exposures.
This study and that of Baxter et al. (25) confirm the limited diagnostic reliability of death certificate diagnosis of HAS and the need to assess a variety of sources of data in order to identify cases for studies of rare tumors such as HAS.
The Thorotrast data are instructive because the initial estimate of the latency period has lengthened with time; recent cases have been in individuals who had relatively low-dose procedures but prolonged latent periods (16) . This accentuates the need to continue evaluation of VCM exposed groups for the possible appearance of a similar pattern. The time frame covered by our study is perhaps too early to detect a sizable number of cases with relatively low VCM exposure either in occupational or environmental settings. In addition, Thorotrastinduced HAS was noted approximately 10 years before Thorotrast-induced hepatocellular tumors were recognized; given the identical morphologic appearance after VCM exposure, involving mixed hyperplasia of sinusoidal cells and hepatocytes, and the occurrence of hepatocellular tumors in experimental animals exposed to VCM (26), we need to continue to follow-up VCM-exposed cohorts for the possible appearance of hepatocellular tumors.
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